Fosfomycin increases chromosome instability in lymphocytes from Fanconi Anemia patients.

[1]  Sanjay S. Patel,et al.  Fosfomycin Tromethamine , 1997, Drugs.

[2]  F. Pallardó,et al.  Oxidative stress in Fanconi anaemia: from cells and molecules towards prospects in clinical management , 2012, Biological chemistry.

[3]  A. Michalopoulos,et al.  The revival of fosfomycin. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  A. Leithner,et al.  A Reappraisal of Current Dosing Strategies for Intravenous Fosfomycin in Children and Neonates , 2011, Clinical pharmacokinetics.

[5]  A. Auerbach,et al.  Mutations of the SLX4 gene in Fanconi anemia , 2011, Nature Genetics.

[6]  C. Joukhadar,et al.  Fosfomycin: an old, new friend? , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[7]  M. Falagas,et al.  Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. , 2009, International journal of antimicrobial agents.

[8]  P. Muganda,et al.  Diepoxybutane activates the mitochondrial apoptotic pathway and mediates apoptosis in human lymphoblasts through oxidative stress. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  N. Tretyakova,et al.  The 5'-GNC site for DNA interstrand cross-linking is conserved for diepoxybutane stereoisomers. , 2006, Chemical research in toxicology.

[10]  H. Joenje,et al.  Effect of oxygen tension on chromosomal aberrations in Fanconi anaemia , 2004, Human Genetics.

[11]  P. Degan,et al.  Diepoxybutane and mitomycin C toxicity is associated with the induction of oxidative DNA damage in sea urchin embryos , 2001, Human & experimental toxicology.

[12]  M. Warnau,et al.  Redox-dependent toxicity of diepoxybutane and mitomycin C in sea urchin embryogenesis. , 2000, Carcinogenesis.

[13]  A. Wonacott,et al.  Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin. , 1996, Structure.

[14]  J. A. Bond,et al.  The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro. , 1996, Toxicology and applied pharmacology.

[15]  E. Brown,et al.  MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in Escherichia coli , 1995, Journal of bacteriology.

[16]  A. Rogatko,et al.  International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. , 1989, Blood.

[17]  H. Joenje,et al.  Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia , 1981, Nature.

[18]  R. Chaganti,et al.  Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. , 1981, Pediatrics.

[19]  I. Nordenson,et al.  Effect of superoxide dismutase and catalase on spontaneously occurring chromosome breaks in patients with Fanconi's anemia , 2009 .

[20]  H. Kropp,et al.  THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN) , 1974, Annals of the New York Academy of Sciences.